新藥研發大部分的時間與經費均投入在臨床試驗，因此，選定最佳的臨床試驗設計及統計方法，不僅可成功且加速臨床試驗，更可節省研發經費與時程，及早造福病患。「2021藥物開發之關鍵臨床計畫國際研討會」為藥物開發之關鍵臨床計畫國際研討會，探討包含調適性設計、精準醫療及真實世界資料/證據等當代最新議題。在此會議中，國內外專家學者講述其專業領域從過去到最新的發展與法規概況，並同時讓參與各界學員由此能有機會與國內外大師進行對話，進一步地促進國內外學者學術交流， 藉由這些學界領導者，帶入最新的概念與知識，達到帶動與鼓勵投入相關領域發展與研究的目的。
Huge cost and long-drawn time-frame associated with drug development, coupled with high rate of late phase attrition is recognized as primary reason for stagnation in clinical development. To explore optimal trial design and synthesis of evidence based on theoretical and statistical methods can enhance trial efficiency, without undermining the validity and integrity of the trial. "2021 Conference of Critical Clinical Initiatives in Drug Development" will include inspiring speakers from Taiwan and international Institutions, and industry. The goal is to more fully understand the issues surrounding adaptive design, precision medicine, and real-world data/evidence, including regulatory concepts and experiences.
線上研討會直播網址將於會議舉辦日前以E-mail提供
Live Webinar Link will be sent before september 17, 2021
研討會議程與C.V.請掃描QR Code (下載連結)
Scan QR Code for download Agenda and C.V. (Link)
本研討會將提供【西醫師/藥師】繼續教育積分
主辦單位 Organized by：
長庚醫療財團法人林口長庚紀念醫院 臨床試驗中心
Clinical Trial Center, Linkou Chang Gung Memorial Hospital, Taiwan
財團法人醫藥品查驗中心
Center for drug evaluation, Taiwan
指導單位 Directed by：
衛生福利部
Ministry of health and welfare, Taiwan
